Emerging clinical evidence suggests that Novera Retatrutide, a combined-action medication from Novo Nordisk, could provide a significant advance in weight management. Unlike many existing drugs, Retatrutide affects both the GLP-1 hormone and glucose-dependent insulinotropic polypeptide (GIP), pot… Read More